Skip to content

Clinical study on the safety and efficacy of human embryonic stem cell-derived retinal pigment epithelial cells transplantation for the treatment of macular hole of high myopia

Clinical study on the safety and efficacy of human embryonic stem cell-derived retinal pigment epithelial cells transplantation for the treatment of macular hole of high myopia

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200055625
Enrollment
Unknown
Registered
2022-01-15
Start date
2022-01-15
Completion date
Unknown
Last updated
2023-02-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

High myopia macular hole

Interventions

experimental group:Retinal pigment epithelial cells are transplanted into the macular hole area

Sponsors

Chongqing Southwest Hospital Ophthalmology Department
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Volunteer as the subject, and the patient signs the informed consent; 2. Aged between 18 and 65 years, regardless of gender; 3. OCT examination confirmed the diagnosis of idiopathic macular hole; 4. Patients with large aperture (horizontal distance at the narrowest part of the hole > 700 µm) or patients with a long course of disease (duration >= 6 months) or those with previous retinal detachment repositioning or vitreous surgery.

Exclusion criteria

Exclusion criteria: 1. Patients with optic neuropathy, corneal disease, glaucoma, uveitis and other vitreoretinal diseases; 2. Combined with severe cardiovascular, liver, kidney and hematopoietic system and other primary diseases, mental illness; 3. Systemic or local use of other drugs that affect the evaluation of efficacy, such as glucocorticoids; 4. Pregnant and lactating women; 5. Those who have participated in other clinical trials in the past three months.

Design outcomes

Primary

MeasureTime frame
Best corrected visual acuity;Intraocular Pressure;Fundus Photography;Spectral Domain Opticalcoherence Tomography, SD-OCT;

Countries

China

Contacts

Public ContactYong Liu

Chongqing Southwest Hospital Ophthalmology Department

liuyy99@163.com+86 13983732105

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026